|
1
|
He L and Hannon GJ: MicroRNAs: small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar
|
|
5
|
Iorio MV, Visone R, Di Leva G, Donati V,
Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H,
Calin GA, Menard S and Croce CM: MicroRNA signatures in human
ovarian cancer. Cancer Res. 67:8699–8707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim
JH, Kim JW and Kim S: MicroRNA expression profiles in serous
ovarian carcinoma. Clin Cancer Res. 14:2690–2695. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang L, Volinia S, Bonome T, Calin GA,
Greshock J, Yang N, Liu CG, Giannakakis A, Alexiou P, Hasegawa K,
Johnstone CN, Megraw MS, Adams S, Lassus H, Huang J, Kaur S, Liang
S, Sethupathy P, Leminen A, Simossis VA, Sandaltzopoulos R, Naomoto
Y, Katsaros D, Gimotty PA, DeMichele A, Huang Q, Butzow R, Rustgi
AK, Weber BL, Birrer MJ, Hatzigeorgiou AG, Croce CM and Coukos G:
Genomic and epigenetic alterations deregulate microRNA expression
in human epithelial ovarian cancer. Proc Natl Acad Sci USA.
105:7004–7009. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang H, Kong W, He L, Zhao JJ, O’Donnell
JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV and Cheng JQ:
MicroRNA expression profiling in human ovarian cancer: miR-214
induces cell survival and cisplatin resistance by targeting PTEN.
Cancer Res. 68:425–433. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dahiya N, Sherman-Baust CA, Wang TL,
Davidson B, Shih IeM, Zhang Y, Wood W III, Becker KG and Morin PJ:
MicroRNA expression and identification of putative miRNA targets in
ovarian cancer. PLoS One. 3:e24362008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wyman SK, Parkin RK, Mitchell PS, Fritz
BR, O’Briant K, Godwin AK, Urban N, Drescher CW, Knudsen BS and
Tewari M: Repertoire of microRNAs in epithelial ovarian cancer as
determined by next generation sequencing of small RNA cDNA
libraries. PLoS One. 4:e53112009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang L, Huang J, Yang N, Greshock J,
Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR,
Yao G, Medina A, O’brien-Jenkins A, Katsaros D, Hatzigeorgiou A,
Gimotty PA, Weber BL and Coukos G: microRNAs exhibit high frequency
genomic alterations in human cancer. Proc Natl Acad Sci USA.
103:9136–9141. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Merritt WM, Lin YG, Han LY, Kamat AA,
Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick
AM, Deavers MT, Mourad-Zeidan A, Wang H, Mueller P, Lenburg ME,
Gray JW, Mok S, Birrer MJ, Lopez-Berestein G, Coleman RL, Bar-Eli M
and Sood AK: Dicer, Drosha, and outcomes in patients with ovarian
cancer. N Engl J Med. 359:2641–2650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dahiya N and Morin PJ: MicroRNAs in
ovarian carcinomas. Endocr Relat Cancer. 17:F77–89. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Garofalo M and Croce CM: microRNAs: Master
regulators as potential therapeutics in cancer. Annu Rev Pharmacol
Toxicol. 51:25–43. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Linsley PS, Schelter J, Burchard J,
Kibukawa M, Martin MM, Bartz SR, Johnson JM, Cummins JM, Raymond
CK, Dai H, Chau N, Cleary M, Jackson AL, Carleton M and Lim L:
Transcripts targeted by the microRNA-16 family cooperatively
regulate cell cycle progression. Mol Cell Biol. 27:2240–2252. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He L, He X, Lim LP, de Stanchina E, Xuan
Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL,
Linsley PS, Chen C, Lowe SW, Cleary MA and Hannon GJ: A microRNA
component of the p53 tumour suppressor network. Nature.
447:1130–1134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Georges SA, Biery MC, Kim SY, Schelter JM,
Guo J, Chang AN, Jackson AL, Carleton MO, Linsley PS, Cleary MA and
Chau BN: Coordinated regulation of cell cycle transcripts by
p53-inducible microRNAs, miR-192 and miR-215. Cancer Res.
68:10105–10112. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lim LP, Lau NC, Garrett-Engele P, Grimson
A, Schelter JM, Castle J, Bartel DP, Linsley PS and Johnson JM:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mishra PJ and Merlino G: MicroRNA
reexpression as differentiation therapy in cancer. J Clin Invest.
119:2119–2123. 2009.PubMed/NCBI
|
|
21
|
Wahid F, Shehzad A, Khan T and Kim YY:
MicroRNAs: synthesis, mechanism, function, and recent clinical
trials. Biochim Biophys Acta. 1803:1231–1243. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsuruo T, Hamilton TC, Louie KG, Behrens
BC, Young RC and Ozols RF: Collateral susceptibility of
adriamycin-, melphalanand cisplatin-resistant human ovarian tumor
cells to bleomycin. Jpn J Cancer Res. 77:941–945. 1986.PubMed/NCBI
|
|
23
|
Nakano H, Miyazawa T, Kinoshita K, Yamada
Y and Yoshida T: Functional screening identifies a microRNA,
miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal
cancer cells. Int J Cancer. 127:1072–1080. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Creighton CJ, Nagaraja AK, Hanash SM,
Matzuk MM and Gunaratne PH: A bioinformatics tool for linking gene
expression profiling results with public databases of microRNA
target predictions. RNA. 14:2290–2296. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kefas B, Godlewski J, Comeau L, Li Y,
Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S and
Purow B: microRNA-7 inhibits the epidermal growth factor receptor
and the Akt pathway and is down-regulated in glioblastoma. Cancer
Res. 68:3566–3572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kozaki K, Imoto I, Mogi S, Omura K and
Inazawa J: Exploration of tumor-suppressive microRNAs silenced by
DNA hypermethylation in oral cancer. Cancer Res. 68:2094–2105.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Voorhoeve PM, le Sage C, Schrier M, Gillis
AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A,
Zlotorynski E, Yabuta N, De Vita G, Nojima H, Looijenga LH and
Agami R: A genetic screen implicates miRNA-372 and miRNA-373 as
oncogenes in testicular germ cell tumors. Adv Exp Med Biol.
604:17–46. 2007. View Article : Google Scholar
|
|
28
|
Nijhawan D, Fang M, Traer E, Zhong Q, Gao
W, Du F and Wang X: Elimination of Mcl-1 is required for the
initiation of apoptosis following ultraviolet irradiation. Genes
Dev. 17:1475–1486. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lujambio A, Ropero S, Ballestar E, Fraga
MF, Cerrato C, Setien F, Casado S, Suarez-Gauthier A,
Sanchez-Cespedes M, Git A, Spiteri I, Das PP, Caldas C, Miska E and
Esteller M: Genetic unmasking of an epigenetically silenced
microRNA in human cancer cells. Cancer Res. 67:1424–1429. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Braun CJ, Zhang X, Savelyeva I, Wolff S,
Moll UM, Schepeler T, Orntoft TF, Andersen CL and Dobbelstein M:
p53-responsive micrornas 192 and 215 are capable of inducing cell
cycle arrest. Cancer Res. 68:10094–10104. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ovcharenko D, Kelnar K, Johnson C, Leng N
and Brown D: Genome-scale microRNA and small interfering RNA
screens identify small RNA modulators of TRAIL-induced apoptosis
pathway. Cancer Res. 67:10782–10788. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Iliopoulos D, Rotem A and Struhl K:
Inhibition of miR-193a expression by Max and RXRalpha activates
K-Ras and PLAU to mediate distinct aspects of cellular
transformation. Cancer Res. 71:5144–5153. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen J, Zhang X, Lentz C, Abi-Daoud M,
Pare GC, Yang X, Feilotter HE and Tron VA: miR-193b Regulates Mcl-1
in Melanoma. Am J Pathol. 179:2162–2168. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu C, Liu S, Fu H, Li S, Tie Y, Zhu J,
Xing R, Jin Y, Sun Z and Zheng X: MicroRNA-193b regulates
proliferation, migration and invasion in human hepatocellular
carcinoma cells. Eur J Cancer. 46:2828–2836. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rauhala HE, Jalava SE, Isotalo J, Bracken
H, Lehmusvaara S, Tammela TL, Oja H and Visakorpi T: miR-193b is an
epigenetically regulated putative tumor suppressor in prostate
cancer. Int J Cancer. 127:1363–1372. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gao XN, Lin J, Gao L, Li YH, Wang LL and
Yu L: MicroRNA-193b regulates c-Kit proto-oncogene and represses
cell proliferation in acute myeloid leukemia. Leuk Res.
35:1226–1232. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen J, Feilotter HE, Pare GC, Zhang X,
Pemberton JG, Garady C, Lai D, Yang X and Tron VA: MicroRNA-193b
represses cell proliferation and regulates cyclin D1 in melanoma.
Am J Pathol. 176:2520–2529. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Baek D, Villen J, Shin C, Camargo FD, Gygi
SP and Bartel DP: The impact of microRNAs on protein output.
Nature. 455:64–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Selbach M, Schwanhausser B, Thierfelder N,
Fang Z, Khanin R and Rajewsky N: Widespread changes in protein
synthesis induced by microRNAs. Nature. 455:58–63. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Leivonen SK, Makela R, Ostling P, Kohonen
P, Haapa-Paananen S, Kleivi K, Enerly E, Aakula A, Hellstrom K,
Sahlberg N, Kristensen VN, Borresen-Dale AL, Saviranta P, Perala M
and Kallioniemi O: Protein lysate microarray analysis to identify
microRNAs regulating estrogen receptor signaling in breast cancer
cell lines. Oncogene. 28:3926–3936. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Leivonen SK, Rokka A, Ostling P, Kohonen
P, Corthals GL, Kallioniemi O and Perala M: Identification of
miR-193b targets in breast cancer cells and systems biological
analysis of their functional impact. Mol Cell Proteomics.
10:M110.0053222011. View Article : Google Scholar : PubMed/NCBI
|
